| Matching Funds Grant Program | |
|---|---|
|
Please Distribute Widely
- Help us to help reform by forwarding this
message or the URL below to your email lists, friends, and acquaintances.
http://drugsense.org/donate/matching.htm Dear Fellow Reformer: Are you one of the 20,000 people per day who use DrugSense/MAP Services? Are you able to help us to become even better at promoting sensible drug polices? DrugSense/MAP has an urgent request and some very good news. If you can provide support to DrugSense as described below, a generous contributor, who prefers to remain anonymous, has agreed to match your contribution up to $250. So every dollar contributed results in TWO dollars donated to DrugSense and MAP. You can donate simply by visiting http://www.drugsense.org/donate/ and either make a credit card contribution, or use your Paypal account. An exciting new feature has been added to our donations web site. If you have the ability, you can now contribute periodically and automatically on a regular basis by filling out a very simple form. Again, please see http://www.drugsense.org/donate/ If you prefer you can mail in your check. Please be sure to note that your contribution is in conjunction with the "Matching Funds Grant Program" to insure your contribution has double the impact. If you prefer to contribute by check please mail your contribution to:
DrugSense Why Should I donate to DrugSense/MAP? To build MAP / DrugSense into one of the world's largest and most popular drug policy reform web sites http://www.drugsense.org/webpop/ and to generate more than 13,000 published letters to editors http://www.mapinc.org/lte/ over the course of the past few years, a handful of us have devoted some sixty or seventy hours a week with tiny remuneration. One of our greatest strengths is the hundreds of volunteers who donate hours of their time each week to make this endeavor possible. We are proud of our current services, which include; The DrugNews archive of more than 110,000 fully searchable news articles on drug policy issues, http://www.mapinc.org/drugnews/ The DrugSense Weekly newsletter, currently read by more than 20,000 subscribers and visitors a week http://www.drugsense.org/current.htm DrugSense provides 100% subsidized hosting, tech support and Internet services to almost all of the drug policy reform organizations in the Drug Policy Central client database, ranging from MPP and NORML to the Drug Policy Alliance and from the Harm Reduction Coalition to scores of state- and issue-focused groups. In turn, DPC clients form a major portion of the drug reform movement, so our continuing presence means the continuing presence of 135 drug-related web sites. http://www.drugsense.org/sitemap.htm We have dreams of expanding our services in the near future, including the recently announced fully functional media contact database available to the entire reform movement. This will enable any reformer to contact not only newspapers, but radio talk shows, local TV stations, corporations and many other influential contacts worldwide. But as much as we desire to maintain core services and expand programs, I must tell you that we face serious financial straits, in part because our initial funders of seed money are now pressing us to attract more support from the thousands of drug policy oriented individuals who utilize our services every day. So I must get out my beggar's cup and ask whether you would help support our organization with a contribution within your means, be it ten dollars, fifty dollars, five hundred dollars or whatever you can manage. Remember every dollar you contribute up to $250 results in a matching contribution from our generous benefactor who prefers to remain anonymous. For those of you who may not be fully familiar with DrugSense/MAP and who wish to review our many and varied accomplishments and services on behalf of more sensible drug policies in more detail, please take a few minutes to review: http://www.drugsense.org/grant2003/ Thank you for joining us in bringing about more sensible drug policy reform and justice. Mark |